HFT Trading Indictment, page-11

No none likes to hear that there maybe a share market meltdown in the near future. Batten down the hatches and storm proof your investments.

I personally invest in companies that show a history of good core business management and have a potential for steady growth in areas of specialist areas of ethical value.

I think on this.....population percentage of heart disease is increasing around the world at a almost epidemic, as their is a pandemic rise in obesity rates increasing around the world.

What is my opinion of the strategy of Admedus having knowledge of what they are doing publishing in public news forums?

I believe, the release of Admedus information in media as far as it can, is not completely a goal of Admedus to push up share price in a hurry.

Getting back to the epidemic rise in heart disease. In my opinion one of the many ways to promote good heart health surgery intervention information to the world population via the media, is to inform people of what is available now. Such information gives hope and choice. It also builds business through demand.


The cost of rebuilding heart valves, and other cardiac disease treatment with CardioCel in many cases will be a far better medical procedure than what is currently available. For example, replacing leaking heart valves with artificial titanium heart valves at a cost of around $15,000 - $20,000 each.

I not only love Bentley's, I have heart disease. I have read widely on what is available to treat heart disease. Also, I am a medical clinician. In my practice, have have had engaging discussions with many Cardiologist's, heart surgeon's.

CardioCel in Australia, is getting a very good report card among leading specialist heart clinicians and surgeons. If down the track, I again require heart surgery intervention, I hope CardioCel will be an option for me to choose from.

I have spoken to many other people around the world with heart disease. I have sat in heart specialist waiting rooms and participate in heart disease support groups around the world. CardioCel is becoming part of the heart disease treatment pathway discussions for many people around the world.

People are now asking their heart surgeons if CardioCel is a choice for them.
If I need heart surgery again, CardioCel will be an option discussion I will be having with my heart specialist clinicians.

Thank you Admedus
MB